Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022

Matthew Sykes Maintained (TWST) at Hold with Decreased Target to $55 on, Apr 13th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-55-on-apr-13th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Hold with Decreased Target from $105 to $55 on, Apr 13th, 2022.

Matthew has made no other calls on TWST in the last 4 months.



There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Puneet Souda of "SVB Leerink" Maintained at Hold with Decreased Target to $70 on, Monday, February 7th, 2022


This is the rating of the analyst that currently disagrees with Matthew


  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $75 on, Monday, February 7th, 2022